Clinical trial
Autologous Adipose Stromal Vascular Fraction Outcomes in Rheumatoid Arthritis Research Study
NCT02348086 is registered in ClinicalTrials.gov with StemGenex as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Adipose Stromal Vascular Fraction Outcomes in Rheumatoid Arthritis Research Study
- Lead sponsor
- StemGenex
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- May 31, 2019
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis